Subsequent experiments showed that RNF13 improves glycolipid metabolism, inflammatory damage, and fibrosis in NAFLD by inhibiting the natural immune cGAS-STING pathway (93) (Figure 2). This evidence concerns the gene STING1 and metabolic dysfunction-associated steatotic liver disease.